1.Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes.
Younghyup LIM ; Soyeon YOO ; Sang Ah LEE ; Sang Ouk CHIN ; Dahee HEO ; Jae Cheol MOON ; Shinhang MOON ; Kiyoung BOO ; Seong Taeg KIM ; Hye Mi SEO ; Hyeyoung JWA ; Gwanpyo KOH
Endocrinology and Metabolism 2015;30(2):208-215
BACKGROUND: Increased low density lipoprotein cholesterol (LDL-C) level and the presence of metabolic syndrome (MetS) are important risk factors for cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). Recent studies demonstrated apolipoprotein B (apoB), a protein mainly located in LDL-C, was an independent predictor of the development of CVD especially in patients with T2DM. The aim of this study was to investigate the relationship between apoB and MetS in T2DM patients. METHODS: We analyzed 912 patients with T2DM. Fasting blood samples were taken for glycated hemoglobin, high-sensitivity C-reactive protein, total cholesterol, triglyceride (TG), high density lipoprotein cholesterol, LDL-C, and apoB. MetS was defined by the modified National Cholesterol Education Program Adult Treatment Panel III criteria. We performed a hierarchical regression analysis with apoB as the dependent variable. Age, sex, the number of components of MetS and LDL-C were entered at model 1, the use of lipid-lowering medications at model 2, and the individual components of MetS were added at model 3. RESULTS: Seventy percent of total subjects had MetS. ApoB level was higher in subjects with than those without MetS (104.5+/-53.3 mg/dL vs. 87.7+/-33.7 mg/dL, P<0.01) even after adjusting for LDL-C. ApoB and LDL-C were positively correlated to the number of MetS components. The hierarchical regression analysis showed that the increasing number of MetS components was associated with higher level of apoB at step 1 and step 2 (beta=0.120, P<0.001 and beta=0.110, P<0.001, respectively). At step 3, TG (beta=0.116, P<0.001) and systolic blood pressure (beta=0.099, P<0.05) were found to significantly contribute to apoB. CONCLUSION: In patients with T2DM, apoB is significantly related to MetS independently of LDL-C level. Of the components of MetS, TG, and systolic blood pressure appeared to be determinants of apoB.
Adult
;
Apolipoproteins B
;
Apolipoproteins*
;
Blood Pressure
;
C-Reactive Protein
;
Cardiovascular Diseases
;
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL*
;
Diabetes Mellitus, Type 2
;
Education
;
Fasting
;
Hemoglobin A, Glycosylated
;
Humans
;
Risk Factors
;
Triglycerides
2.Anaphylaxis caused by muscle relaxant (eperisone hydrochloride).
Sung Hyun KIM ; Jaechun LEE ; Su Hee KIM ; Hyun Woo KIM ; Young Uck KIM ; Younghyup LIM ; Shinhang MOON ; Jaecheol MOON ; Dahee HEO
Allergy, Asthma & Respiratory Disease 2013;1(2):172-175
Eperisone hydrochloride is an antispasmodic drug, decreasing spasticity of skeletal muscle and alleviating stiffness, and as a consequence, controlling pain. It is preferably prescribed with other analgesics, beneficially less decreasing alertness compared with other antispasmodics. Its fatal drug adverse reactions were rarely reported. A 70 year-old female with hives, swollen face, hoarse voice, and near fainting admitted via emergency department. She suffered from the series of the fatal symptoms after administration of the pills, prescribed for her neck pain. Two months before, she had experienced hives on similar medications. At presentation, she revealed hypoxemia and hypotension, and treated with epinephrine, glucocorticoids and antihistamines. Among the medicines she took, eperisone hydrochloride was proven as the causative medicine and others were excluded in oral provocation tests. The positive result in intradermal test with eperisone hydrochloride suggested immediate-type hypersensitivity reaction. We report a case of anaphylaxis to eperisone hydrochloride, one of the widely prescribed medicines in clinical practice, previously without awareness of drug adverse reaction.
Analgesics
;
Anaphylaxis
;
Anoxia
;
Drug Hypersensitivity
;
Emergencies
;
Epinephrine
;
Female
;
Glucocorticoids
;
Histamine Antagonists
;
Humans
;
Hypersensitivity
;
Hypersensitivity, Immediate
;
Hypotension
;
Intradermal Tests
;
Muscle Spasticity
;
Muscle, Skeletal
;
Muscles
;
Neck Pain
;
Parasympatholytics
;
Propiophenones
;
Syncope
;
Urticaria
;
Voice